Cross-institution positioning
Aug 13, 2026Reduction leaning. 1 reducing across 1 comparable institution.
Source: Schedule 13 researchTERAWULF INC.
Latest stored close $13.77 as of Oct 9, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Reduction leaning. 1 reducing across 1 comparable institution.
Source: Schedule 13 research0 increased/new, 2 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 3 purchases by 1 reporting owner and 3 sales by 3 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/52 non-amendment material events in the last 90 days; Latest classified evidence: Other event. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue -6.0% YoY; Net income -5,016.6% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 22% through its reported 52-week range; +38.1% over one year.
Source: Stored historical price seriesFiled Aug 13, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Bucella Michael C. | AGrant, award, or other acquisition | Common stock, $0.001 par value per share | 1.7K | — | Direct | Oct 2, 2026 |
| Sep 30, 2026 | Carter Walter E. | AGrant, award, or other acquisition | Common stock, $0.001 par value per share | 2.1K | — | Direct | Oct 2, 2026 |
| Sep 30, 2026 | Prager Lisa A. | AGrant, award, or other acquisition | Common stock, $0.001 par value per share | 1.7K | — | Direct | Oct 2, 2026 |
| Sep 29, 2026 | Khan Nazar M. | MExercise or conversion of derivative · derivative | Restricted Stock Units | 666.7K | — | Direct | Sep 29, 2026 |
| Sep 29, 2026 | Khan Nazar M. | MExercise or conversion of derivative | Common stock, $0.001 par value per share | 666.7K | — | Direct | Sep 29, 2026 |
| Sep 22, 2026 | Prager Paul B. | JOther transaction · derivative | Forward sale contract (obligation to sell) | 3.0M | — | Indirect | Sep 23, 2026 |
| Sep 15, 2026 | Bucella Michael C. | POpen-market or private purchase | Common stock, $0.001 par value per share | 6.1K | $14.79 | Direct | Sep 16, 2026 |
| Sep 10, 2026 | Khan Nazar M. | JOther transaction · derivative | Forward sale contract (obligation to sell) | 350.0K | — | Indirect | Sep 11, 2026 |
| Sep 10, 2026 | Khan Nazar M. | JOther transaction · derivative | Forward sale contract (obligation to sell) | 350.0K | — | Indirect | Sep 11, 2026 |
| Sep 8, 2026 | Motz Catherine J. | SOpen-market or private sale | Common stock, $0.001 par value per share | 56.0K | $17.81 | Direct | Sep 9, 2026 |
| Aug 31, 2026 | Carter Walter E. | SOpen-market or private sale | Common stock, $0.001 par value per share | 130.6K | $15.14 | Direct | Sep 1, 2026 |
| Aug 27, 2026 | Prager Paul B. | SOpen-market or private sale | Common stock, $0.001 par value per share | 137.5K | $17.06 | Indirect | Aug 28, 2026 |
| Aug 17, 2026 | Bucella Michael C. | POpen-market or private purchase | Common stock, $0.001 par value per share | 2.9K | $17.47 | Direct | Aug 17, 2026 |
| Aug 16, 2026 | Tanimoto William Joseph | MExercise or conversion of derivative · derivative | Restricted Stock Units | 6.7K | — | Direct | Aug 17, 2026 |
| Aug 16, 2026 | Tanimoto William Joseph | MExercise or conversion of derivative | Common stock, $0.001 par value per share | 6.7K | — | Direct | Aug 17, 2026 |
| Aug 14, 2026 | Bucella Michael C. | POpen-market or private purchase | Common stock, $0.001 par value per share | 3.0K | $16.54 | Direct | Aug 17, 2026 |
| Aug 3, 2026 | Langlais Kerri M. | DDisposition to issuer | Common stock, $0.001 par value per share | 276.5K | — | Direct | Aug 3, 2026 |
| Aug 1, 2026 | Fleury Patrick | MExercise or conversion of derivative · derivative | Restricted Stock Units | 500.0K | — | Direct | Aug 3, 2026 |
| Aug 1, 2026 | Fleury Patrick | MExercise or conversion of derivative | Common stock, $0.001 par value per share | 500.0K | — | Direct | Aug 3, 2026 |
| Aug 1, 2026 | Langlais Kerri M. | MExercise or conversion of derivative · derivative | Restricted Stock Units | 500.0K | — | Direct | Aug 3, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Oct 5, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Aug 5, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jul 6, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Jun 10, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| May 26, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| May 8, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $44.8M | -6.0% |
| Ended Jun 30, 2025 | $47.6M | — |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Morgan Stanley CIK0000895421 | Jun 30, 2026 observed Aug 13, 2026 filed · 44d Initial Schedule 13G | Initial Schedule 13G | 30.4M | 6.10% | $24.70 | $16.31 | $13.77 |
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 30, 2026 filed · 30d Schedule 13G amendment | Earliest Schedule 13G amendment found | 22.3M | 12.00% | $24.70 | $17.82 | $13.77 |
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment | Reported reduction | 11 -33.6M | 12.00% +3.97 pts | $14.67 | $14.89 | $13.77 |
Compare WULF with other securities showing similar institutional activity or recent accumulation across several tracked institutions.